ifenprodil and conotoxin gv

ifenprodil has been researched along with conotoxin gv in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adams, AC; Keefe, KA; Layer, RT; McCabe, RT1
Dave, JR; Ling, G; Lu, XM; Tortella, FC; Williams, AJ1
Dave, JR; Koenig, ML; Moffett, JR; Tortella, FC; Williams, AJ1
Dodd, PR; Lewis, RJ; Tsai, VW1
Shuaib, A; Wang, CX1
Castellino, FJ; Geiger, JH; Liang, Z; Prorok, M; Sheng, Z1

Reviews

1 review(s) available for ifenprodil and conotoxin gv

ArticleYear
NMDA/NR2B selective antagonists in the treatment of ischemic brain injury.
    Current drug targets. CNS and neurological disorders, 2005, Volume: 4, Issue:2

    Topics: Animals; Brain; Brain Ischemia; Conotoxins; Drug Design; Excitatory Amino Acid Antagonists; Felbamate; Glutamic Acid; Humans; Neuroprotective Agents; Phenylcarbamates; Piperidines; Propylene Glycols; Protein Conformation; Rats; Receptors, N-Methyl-D-Aspartate

2005

Other Studies

5 other study(ies) available for ifenprodil and conotoxin gv

ArticleYear
Effects of conantokins on L-3,4-dihydroxyphenylalanine-induced behavior and immediate early gene expression.
    European journal of pharmacology, 2000, Sep-22, Volume: 404, Issue:3

    Topics: Animals; Antiparkinson Agents; Conotoxins; DNA-Binding Proteins; Drug Interactions; Early Growth Response Protein 1; Excitatory Amino Acid Antagonists; Gene Expression; Genes, fos; Genes, Immediate-Early; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Levodopa; Male; Mollusk Venoms; Peptides; Pipecolic Acids; Piperidines; Rats; Rats, Sprague-Dawley; Transcription Factors

2000
Selective NR2B NMDA receptor antagonists are protective against staurosporine-induced apoptosis.
    European journal of pharmacology, 2002, Sep-27, Volume: 452, Issue:1

    Topics: Animals; Apoptosis; Cell Survival; Cells, Cultured; Conotoxins; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Nerve Degeneration; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Staurosporine

2002
Studies on neuronal apoptosis in primary forebrain cultures: neuroprotective/anti-apoptotic action of NR2B NMDA antagonists.
    Neurotoxicity research, 2003, Volume: 5, Issue:4

    Topics: Animals; Apoptosis; Caspase 3; Caspases; Cells, Cultured; Conotoxins; Dizocilpine Maleate; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Female; Mexiletine; Neurons; Neuroprotective Agents; Piperidines; Pregnancy; Prosencephalon; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Sodium Channel Blockers; Staurosporine

2003
The effects of alanine-substituted conantokin-G and ifenprodil on the human spermine-activated N-methyl-D-aspartate receptor.
    Neuroscience, 2005, Volume: 130, Issue:2

    Topics: Alanine; Binding, Competitive; Cell Membrane; Cerebral Cortex; Conotoxins; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Humans; Neurons; Neurotoxins; Piperidines; Radioligand Assay; Receptors, N-Methyl-D-Aspartate; Spermine

2005
The selectivity of conantokin-G for ion channel inhibition of NR2B subunit-containing NMDA receptors is regulated by amino acid residues in the S2 region of NR2B.
    Neuropharmacology, 2009, Volume: 57, Issue:2

    Topics: Amino Acid Sequence; Animals; Cell Line; Conotoxins; Excitatory Amino Acid Antagonists; Glycine; Humans; Membrane Potentials; Models, Molecular; Molecular Sequence Data; N-Methylaspartate; Patch-Clamp Techniques; Piperidines; Point Mutation; Rats; Receptors, N-Methyl-D-Aspartate; Recombinant Proteins

2009